COOL-“I Would Choose SkinTE Every Time,”

ir.polarityte.com/press-releases/detail/423

“I Would Choose SkinTE Every Time,” says Patient Treated with PolarityTE’s New Skin Regeneration Product


DOWNLOAD AS PDF APRIL 18, 2018


SALT LAKE CITY, April 18, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ:COOL) today announced continued success with SkinTE during its limited-market release across a variety of conditions, including burns, wounds, surgical reconstruction and the replacement of skin grafts.



“We at PolarityTE are incredibly excited to see the success of SkinTE throughout such a wide spectrum of patients in such a short period of time. We expect to receive additional clinical results through multiple channels, such as case studies, peer-reviewed publications and a PolarityTE hosted Key Opinion Leader (KOL) Summit to learn more about SkinTE in clinical practice from early adopters. In the end, however, the most important outcome is the impact on the patient’s life,” said Dr. Denver Lough, CEO of PolarityTE.



Among the outcomes observed are a SkinTE case involving a patient who suffered from a large chronic leg wound for multiple years. Prior failed treatment attempts included not only other wound care products, but also two failed skin grafts. Skin grafts have traditionally been considered the clinical standard of care in covering both small and large wounds.



Devon, who was treated with SkinTE, commented: “After a motorcycle accident a few years ago, I was treated for several injuries; however, wounds on my leg were persistent and after trying a few different options for treatment, nothing was working. We eventually tried two skin grafts, which took many months for any healing, and each time we removed those bandages, about 75 percent of the graft came off with the bandage. These non-healing wounds were limiting my ability to do physical therapy and fully recover because the wounds would bleed through the bandages. Then, a few weeks ago, I was treated with a new product – SkinTE – and it has already provided nearly full coverage of the wounds and healing is a lot better than it was with the other stuff we tried. My leg feels as close to normal skin as I can imagine, and there is even some hair growth. If I had to choose between SkinTE and another skin graft, I would choose SkinTE every time because it is actually working, and you don’t have a huge area of healthy skin removed that also then needs to heal, like with traditional skin grafts.”



Dr. Mark S. Granick, MD, Professor and Chief of Plastic Surgery at Rutgers New Jersey Medical School and an early adopter of SkinTE commented on his experience with the product: “I recently used SkinTE on a patient with a significantly sized leg wound which was the result of a traumatic skin avulsion. A hyper-granulating wound had persisted for more than two years despite treatments with currently available options, including split thickness skin grafts. The wound was painful, and long-term dressing care was insufficient for returning this otherwise healthy 39-year-old to his pre-injury function level.”



Dr. Granick continued, “Ultimately, the best thing for this patient, and generally any patient who is suffering with wounds, is to replace his own skin. SkinTE seems to be providing that. Thus far in the healing process, SkinTE has resulted in what appears to be full-thickness, pigmented skin regeneration. Certainly, in this case, SkinTE provided superior results with a quicker and less invasive procedure. I look forward to continuing to evaluate the potential and capabilities of this exciting and ground-breaking product.”



“Nothing speaks more highly of the product’s success than a patient testimonial,” said Dr. Ned Swanson, Chief Operating Officer of PolarityTE. Dr. Swanson continued, “The remainder of 2018 will be dedicated to building robust clinical packages across all wound types in concert with this first phase rollout, and we look forward to sharing additional information about these exciting outcomes.”

Crusher